Evidence map›Paper›PMID 41884390›Full record

ArticleClinical, cosmetic and investigational dermatology2026

A Case of Angioimmunoblastic T-Cell Lymphoma Misdiagnosed as Eczema-Like Dermatitis in an Elderly Patient.

Lanqing Xie, Zeyu Huang, Ruzhi Zhang

Abstract readCase Reports
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lanqing Xie *Department of Dermatology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, People's Republic of China.
Zeyu Huang *Department of Dermatology, The Third Affiliated Hospital of Soochow University, Changzhou, People's Republic of China.ORCID 0009-0006-2898-8278
Ruzhi ZhangDepartment of Dermatology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a clinically heterogeneous subtype of peripheral T-cell lymphoma that frequently presents with nonspecific cutaneous manifestations. Approximately 40%-50% of patients initially develop diffuse erythema or papular eruptions that may mimic benign inflammatory or allergic dermatoses, posing a diagnostic challenge in early disease stages. We report the case of an 81-year-old man who presented with generalized pruritic papules and was initially diagnosed with an eczema-like inflammatory dermatitis. Although the skin lesions showed transient improvement with symptomatic treatment, they recurred repeatedly. The subsequent onset of chills and cervical lymphadenopathy prompted further evaluation, including skin and lymph node biopsies, which established the diagnosis of AITL. Bone marrow involvement was identified by morphologic examination and flow cytometry. Immunohistochemical analysis demonstrated neoplastic T cells expressing CD3, CD4, and CD5, along with follicular helper T-cell-associated markers including CD10, BCL-6, PD-1, and CXCL13, with a Ki-67 proliferation index of approximately 70%. This case underscores the diagnostic complexity of AITL presenting with predominant allergic-like skin lesions and highlights the importance of considering underlying lymphoproliferative disorders in elderly patients with persistent, recurrent, or atypical dermatoses. Timely histopathological and immunophenotypic evaluation is essential for accurate diagnosis and appropriate management.

Indexed as

angioimmunoblastic T-cell lymphomaeczemamisdiagnosed

Identifiers

PMID41884390
PMCPMC13012280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.